DexCom (DXCM)
(Delayed Data from NSDQ)
$127.37 USD
+1.77 (1.41%)
Updated May 24, 2024 04:00 PM ET
After-Market: $127.12 -0.25 (-0.20%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Brokerage Reports
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 401 - 412 ( 412 total )
Company: DexCom, Inc.
Industry: Medical - Products
THE NEXT PERFECT STORM-OBAMACARE WILL STRETCH THE SYSTEM TO ITS ULTIMATE LIMIT
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Q2 Financials Meet Expectations. SEVEN PLUS Demand Remains Strong and New Product Launches Anticipated.
Provider: WEDBUSH SECURITIES INC.
Analyst: LAU R
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Q2 Preview: We are at the Mid-Range of Consensus and Believe Our Estimates are Achievable.
Provider: WEDBUSH SECURITIES INC.
Analyst: LAU R
Company: DexCom, Inc.
Industry: Medical - Products
70TH ANNUALAMERICAN DIABETES ASSOCIATION MEETING CONFIRMS THESIS - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: DexCom, Inc.
Industry: Medical - Products
Life Sciences: Biopharmaceuticals / Biotechnology.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L